18 0 2 0 2 B-lower_bound
- 2 3 2 3 O
65 3 5 3 5 B-upper_bound
years 6 11 6 11 I-upper_bound
old 12 15 12 15 O

Allergic 0 8 16 24 O
to 9 11 25 27 O
or 12 14 28 30 O
has 15 18 31 34 O
had 19 22 35 38 O
a 23 24 39 40 O
severe 25 31 41 47 O
adverse 32 39 48 55 O
reaction 40 48 56 64 O
to 49 51 65 67 O
study 52 57 68 73 B-allergy_name
medication 58 68 74 84 I-allergy_name
( 69 70 85 86 O
i.e. 70 74 86 90 O
opioids 75 82 91 98 B-allergy_name
, 82 83 98 99 O
guanfacine 84 94 100 110 B-allergy_name
, 94 95 110 111 O
lactose 96 103 112 119 B-allergy_name
, 103 104 119 120 O
vitamin 105 112 121 128 B-allergy_name
B2 113 115 129 131 I-allergy_name
a.k.a 116 121 132 137 I-allergy_name
. 121 122 137 138 I-allergy_name
riboflavin 123 133 139 149 I-allergy_name
) 133 134 149 150 O

Any 0 3 151 154 O
medications 4 15 155 166 B-treatment
taken 16 21 167 172 O
by 22 24 173 175 O
a 25 26 176 177 O
subject 27 34 178 185 O
at 35 37 186 188 O
the 38 41 189 192 O
enrollment 42 52 193 203 O
will 53 57 204 208 O
be 58 60 209 211 O
reviewed 61 69 212 220 O
regarding 70 79 221 230 O
their 80 85 231 236 O
compatibility 86 99 237 250 O
with 100 104 251 255 O
guanfacine 105 115 256 266 B-treatment
and 116 119 267 270 O
morphine 120 128 271 279 B-treatment
as 129 131 280 282 O
well 132 136 283 287 O
as 137 139 288 290 O
possible 140 148 291 299 O
confounding 149 160 300 311 O
side 161 165 312 316 O
effects 166 173 317 324 O

Can 0 3 325 328 O
not 3 6 328 331 O
tolerate 7 15 332 340 O
study 16 21 341 346 B-treatment
drugs 22 27 347 352 I-treatment
' 27 28 352 353 O
maximum 29 36 354 361 O
doses 37 42 362 367 O

Chronic 0 7 368 375 B-chronic_disease
neck 8 12 376 380 I-chronic_disease
or 13 15 381 383 O
back 16 20 384 388 B-chronic_disease
pain 21 25 389 393 I-chronic_disease
condition 26 35 394 403 I-chronic_disease
for 36 39 404 407 O
at 40 42 408 410 O
least 43 48 411 416 O
3 49 50 417 418 B-lower_bound
months 51 57 419 425 I-lower_bound

Currently 0 9 426 435 O
in 10 12 436 438 O
a 13 14 439 440 O
treatment 15 24 441 450 B-treatment
program 25 32 451 458 I-treatment
for 33 36 459 462 O
alcohol 37 44 463 470 O
or 45 47 471 473 O
drug 48 52 474 478 O
abuse 53 58 479 484 O
, 58 59 484 485 O
or 60 62 486 488 O
currently 63 72 489 498 O
on 73 75 499 501 O
methadone 76 85 502 511 B-treatment
or 86 88 512 514 O
buprenorphine 89 102 515 528 B-treatment
( 103 104 529 530 O
i.e. 104 108 530 534 O
suboxone 109 117 535 543 B-treatment
, 117 118 543 544 O
subutex 119 126 545 552 B-treatment
) 126 127 552 553 O
for 128 131 554 557 O
treatment 132 141 558 567 O
of 142 144 568 570 O
addiction 145 154 571 580 O
, 154 155 580 581 O
or 156 158 582 584 O
stimulants 159 169 585 595 O
for 170 173 596 599 O
treatment 174 183 600 609 O
of 184 186 610 612 O
ADHD 187 191 613 617 B-chronic_disease

Diagnosed 0 9 618 627 O
with 10 14 628 632 O
Raynaud 15 22 633 640 B-chronic_disease
's 22 24 640 642 I-chronic_disease
syndrome 25 33 643 651 I-chronic_disease

Has 0 3 652 655 O
known 4 9 656 661 O
pre 10 13 662 665 O
- 13 14 665 666 O
existing 14 22 666 674 O
cardiovascular 23 37 675 689 B-chronic_disease
disease 38 45 690 697 I-chronic_disease
( 46 47 698 699 O
i.e. 47 51 699 703 O
arrhythmia 52 62 704 714 B-chronic_disease
- 63 64 715 716 O
prolonged 65 74 717 726 B-clinical_variable
QT 75 77 727 729 I-clinical_variable
interval 78 86 730 738 I-clinical_variable
> 87 88 739 740 O
440ms 89 94 741 746 B-lower_bound
) 94 95 746 747 O
, 95 96 747 748 O
cerebrovascular 97 112 749 764 B-chronic_disease
disease 113 120 765 772 I-chronic_disease
, 120 121 772 773 O
hepatic 122 129 774 781 B-chronic_disease
or 130 132 782 784 O
renal 133 138 785 790 B-chronic_disease
impairment 139 149 791 801 I-chronic_disease
, 149 150 801 802 O
CNS 151 154 803 806 B-chronic_disease
condition 155 164 807 816 I-chronic_disease
, 164 165 816 817 O
metabolic 166 175 818 827 B-chronic_disease
condition 176 185 828 837 I-chronic_disease
, 185 186 837 838 O
or 187 189 839 841 O
history 190 197 842 849 O
of 198 200 850 852 O
syncope 201 208 853 860 B-chronic_disease

Has 0 3 861 864 O
not 4 7 865 868 O
taken 8 13 869 874 O
an 14 16 875 877 O
opioid 17 23 878 884 B-treatment
for 24 27 885 888 O
the 28 31 889 892 O
last 32 36 893 897 B-upper_bound
3 37 38 898 899 I-upper_bound
months 39 45 900 906 I-upper_bound

Has 0 3 907 910 O
other 4 9 911 916 O
chronic 10 17 917 924 O
pain 18 22 925 929 O
conditions 23 33 930 940 O
such 34 38 941 945 O
as 39 41 946 948 O
fibromyalgia 42 54 949 961 B-chronic_disease
or 55 57 962 964 O
joint 58 63 965 970 B-chronic_disease
osteoarthritis 64 78 971 985 I-chronic_disease
that 79 83 986 990 O
are 84 87 991 994 O
predominant 88 99 995 1006 O
over 100 104 1007 1011 O
back 105 109 1012 1016 O
and 110 113 1017 1020 O
neck 114 118 1021 1025 O
pain 119 123 1026 1030 O
with 124 128 1031 1035 O
regard 129 135 1036 1042 O
to 136 138 1043 1045 O
its 139 142 1046 1049 O
intensity 143 152 1050 1059 O
( 153 154 1060 1061 O
VAS 154 157 1061 1064 B-treatment
) 157 158 1064 1065 O

Hypotension 0 11 1066 1077 O
( 12 13 1078 1079 O
SBP 13 16 1079 1082 B-clinical_variable
< 17 18 1083 1084 O
90 19 21 1085 1087 B-upper_bound
mmHg 22 26 1088 1092 I-upper_bound
and 27 30 1093 1096 O
DBP 31 34 1097 1100 B-clinical_variable
< 35 36 1101 1102 O
60 37 39 1103 1105 B-upper_bound
mmHg 40 44 1106 1110 I-upper_bound
for 45 48 1111 1114 O
female 49 55 1115 1121 B-gender
or 56 58 1122 1124 O
SBP 59 62 1125 1128 O
< 63 64 1129 1130 O
100 65 68 1131 1134 B-upper_bound
mmHg 69 73 1135 1139 I-upper_bound
and 74 77 1140 1143 O
DBP 78 81 1144 1147 O
< 82 83 1148 1149 O
60 84 86 1150 1152 O
mmHg 87 91 1153 1157 O
for 92 95 1158 1161 O
male 96 100 1162 1166 O
; 100 101 1166 1167 O
measured 102 110 1168 1176 O
while 111 116 1177 1182 O
in 117 119 1183 1185 O
a 120 121 1186 1187 O
sitting 122 129 1188 1195 O
position 130 138 1196 1204 O
) 138 139 1204 1205 O
or 140 142 1206 1208 O
bradycardia 143 154 1209 1220 O
( 155 156 1221 1222 O
resting 156 163 1222 1229 O
heart 164 169 1230 1235 B-clinical_variable
rate 170 174 1236 1240 I-clinical_variable
< 175 176 1241 1242 O
60 177 179 1243 1245 B-upper_bound
bpm 180 183 1246 1249 I-upper_bound
) 183 184 1249 1250 O

Major 0 5 1251 1256 B-chronic_disease
psychiatric 6 17 1257 1268 I-chronic_disease
disorders 18 27 1269 1278 I-chronic_disease
that 28 32 1279 1283 O
required 33 41 1284 1292 O
hospitalization 42 57 1293 1308 B-treatment
in 58 60 1309 1311 O
the 61 64 1312 1315 O
past 65 69 1316 1320 B-upper_bound
6 70 71 1321 1322 I-upper_bound
months 72 78 1323 1329 I-upper_bound
such 79 83 1330 1334 O
as 84 86 1335 1337 O
: 86 87 1337 1338 O
major 88 93 1339 1344 B-chronic_disease
depression 94 104 1345 1355 I-chronic_disease
, 104 105 1355 1356 O
bipolar 106 113 1357 1364 B-chronic_disease
disorder 114 122 1365 1373 I-chronic_disease
, 122 123 1373 1374 O
schizophrenia 124 137 1375 1388 B-chronic_disease
, 137 138 1388 1389 O
anxiety 139 146 1390 1397 B-chronic_disease
disorder 147 155 1398 1406 I-chronic_disease
, 155 156 1406 1407 O
or 157 159 1408 1410 O
psychotic 160 169 1411 1420 B-chronic_disease
disorders 170 179 1421 1430 I-chronic_disease

Pregnant 0 8 1431 1439 B-pregnancy

Sensory 0 7 1440 1447 O
deficits 8 16 1448 1456 O
at 17 19 1457 1459 O
site 20 24 1460 1464 O
of 25 27 1465 1467 O
QST 28 31 1468 1471 B-clinical_variable
, 31 32 1471 1472 O
such 33 37 1473 1477 O
as 38 40 1478 1480 O
peripheral 41 51 1481 1491 B-chronic_disease
neuropathy 52 62 1492 1502 I-chronic_disease

Subjects 0 8 1503 1511 O
are 9 12 1512 1515 O
on 13 15 1516 1518 O
antihypertensive 16 32 1519 1535 B-treatment
drugs 33 38 1536 1541 I-treatment
( 39 40 1542 1543 O
e.g. 40 44 1543 1547 O
, 44 45 1547 1548 O
a 46 47 1549 1550 O
beta 48 52 1551 1555 B-treatment
- 52 53 1555 1556 I-treatment
blocker 53 60 1556 1563 I-treatment
) 60 61 1563 1564 O
that 62 66 1565 1569 O
result 67 73 1570 1576 O
in 74 76 1577 1579 O
hypotension 77 88 1580 1591 B-chronic_disease
and/or 89 95 1592 1598 O
bradycardia 96 107 1599 1610 B-chronic_disease
as 108 110 1611 1613 O
defined 111 118 1614 1621 O
above 119 124 1622 1627 O

Subjects 0 8 1628 1636 O
are 9 12 1637 1640 O
on 13 15 1641 1643 O
medications 16 27 1644 1655 B-treatment
that 28 32 1656 1660 O
are 33 36 1661 1664 O
ligands 37 44 1665 1672 O
for 45 48 1673 1676 O
alpha2 49 55 1677 1683 B-treatment
- 55 56 1683 1684 I-treatment
adrenergic 56 66 1684 1694 I-treatment
receptors 67 76 1695 1704 I-treatment
including 77 86 1705 1714 O
antipsychotic 87 100 1715 1728 B-treatment
drugs 101 106 1729 1734 I-treatment
( 107 108 1735 1736 O
e.g. 108 112 1736 1740 O
clozapine 113 122 1741 1750 B-treatment
) 122 123 1750 1751 O
and 124 127 1752 1755 O
tricyclic 128 137 1756 1765 B-treatment
or 138 140 1766 1768 O
tetracyclic 141 152 1769 1780 B-treatment
antidepressants 153 168 1781 1796 I-treatment
( 169 170 1797 1798 O
e.g. 170 174 1798 1802 O
imipramine 175 185 1803 1813 B-treatment
, 185 186 1813 1814 O
mirtazapine 187 198 1815 1826 B-treatment
, 198 199 1826 1827 O
mianserin 200 209 1828 1837 B-treatment
) 209 210 1837 1838 O

Subjects 0 8 1839 1847 O
are 9 12 1848 1851 O
on 13 15 1852 1854 O
medications 16 27 1855 1866 B-treatment
that 28 32 1867 1871 O
serve 33 38 1872 1877 O
as 39 41 1878 1880 O
CYP3A4/5 42 50 1881 1889 B-treatment
inhibitors 51 61 1890 1900 I-treatment
or 62 64 1901 1903 O
CYP3A4 65 71 1904 1910 B-treatment
inducers 72 80 1911 1919 I-treatment
including 81 90 1920 1929 O
, 90 91 1929 1930 O
but 92 95 1931 1934 O
are 96 99 1935 1938 O
not 100 103 1939 1942 O
limited 104 111 1943 1950 O
to 112 114 1951 1953 O
, 114 115 1953 1954 O
valproic 116 124 1955 1963 B-treatment
acid 125 129 1964 1968 I-treatment
, 129 130 1968 1969 O
macrolide 131 140 1970 1979 B-treatment
antibiotics 141 152 1980 1991 I-treatment
, 152 153 1991 1992 O
antifungal 154 164 1993 2003 B-treatment
drugs 165 170 2004 2009 I-treatment
, 170 171 2009 2010 O
St. 172 175 2011 2014 B-treatment
John 176 180 2015 2019 I-treatment
wort 181 185 2020 2024 I-treatment
, 185 186 2024 2025 O
ACE 187 190 2026 2029 B-treatment
inhibitors 191 201 2030 2040 I-treatment
, 201 202 2040 2041 O
nefazodone 203 213 2042 2052 B-treatment
( 214 215 2053 2054 O
antidepressant 215 229 2054 2068 B-treatment
) 229 230 2068 2069 O
, 230 231 2069 2070 O
calcium 232 239 2071 2078 B-treatment
channel 240 247 2079 2086 I-treatment
blockers 248 256 2087 2095 I-treatment
, 256 257 2095 2096 O
H2 258 260 2097 2099 B-treatment
- 260 261 2099 2100 I-treatment
receptor 261 269 2100 2108 I-treatment
antagonists 270 281 2109 2120 I-treatment
, 281 282 2120 2121 O
anti 283 287 2122 2126 B-treatment
- 287 288 2126 2127 I-treatment
HIV 288 291 2127 2130 I-treatment
or 292 294 2131 2133 I-treatment
AIDS 295 299 2134 2138 I-treatment
drugs 300 305 2139 2144 I-treatment
, 305 306 2144 2145 O
and 307 310 2146 2149 O
antiepileptic 311 324 2150 2163 B-treatment
drugs 325 330 2164 2169 I-treatment

Takes 0 5 2170 2175 O
vitamin 6 13 2176 2183 B-treatment
B2 14 16 2184 2186 I-treatment
> 17 18 2187 2188 O
1.6mg 19 24 2189 2194 B-lower_bound
/ 24 25 2194 2195 I-lower_bound
day 25 28 2195 2198 I-lower_bound
during 29 35 2199 2205 O
the 36 39 2206 2209 O
study 40 45 2210 2215 O

Tests 0 5 2216 2221 O
positive 6 14 2222 2230 O
for 15 18 2231 2234 O
non 19 22 2235 2238 O
- 22 23 2238 2239 O
study 23 28 2239 2244 O
opioids 29 36 2245 2252 B-treatment
, 36 37 2252 2253 O
illicit 38 45 2254 2261 B-treatment
drugs 46 51 2262 2267 I-treatment
, 51 52 2267 2268 O
marijuana 53 62 2269 2278 B-treatment
, 62 63 2278 2279 O
or 64 66 2280 2282 O
non 67 70 2283 2286 B-treatment
- 70 71 2286 2287 I-treatment
prescribed 71 81 2287 2297 I-treatment
drugs 82 87 2298 2303 I-treatment

VAS 0 3 2304 2307 B-clinical_variable
score 4 9 2308 2313 I-clinical_variable
of 10 12 2314 2316 O
4 13 14 2317 2318 B-lower_bound
- 14 15 2318 2319 O
8 15 16 2319 2320 B-upper_bound

subjects 0 8 2321 2329 O
will 9 13 2330 2334 O
be 14 16 2335 2337 O
warned 17 23 2338 2344 O
of 24 26 2345 2347 O
side 27 31 2348 2352 O
effects 32 39 2353 2360 O
of 40 42 2361 2363 O
morphine 43 51 2364 2372 B-treatment
such 52 56 2373 2377 O
as 57 59 2378 2380 O
sedation 60 68 2381 2389 B-treatment
, 68 69 2389 2390 O
respiratory 70 81 2391 2402 B-chronic_disease
depression 82 92 2403 2413 I-chronic_disease
at 93 95 2414 2416 O
the 96 99 2417 2420 O
enrollment 100 110 2421 2431 O

